Further improvement in anti-tumor immunotherapy was achieved when palmitoylated antigen and lipo-LeY, together with alpha-galactosylceramide (αGC), were combined in a single liposome for their in situ delivery to the skin APCs which enhanced antigen presentation to CD8+ T cell and invariant natural killer T cell (iNKT) activation. Here, CD8A is linked to neoplasm.